NantHealth Announces Pricing of Initial Public Offering

On June 1, 2016, NantHealth, a next-generation personalized healthcare company, announced the pricing of its initial public offering of 6,500,000 shares of its common stock at a price to the public of $14.00 per share. The shares began trading on the Nasdaq Global Select Market on June 2 under the ticker symbol "NH." Wilson Sonsini Goodrich & Rosati is advising NantHealth in the offering.

NantHealth has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of its common stock. Jefferies LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering; First Analysis Securities Corporation, Canaccord Genuity Inc., and FBR Capital Markets & Co. are acting as co-managers.

The WSGR team advising NantHealth in the offering includes partners Jeff Saper, Marty Waters, and Dan Koeppen and associates Megan Baier, Andrew Ellis, and Meg Burton.

For more information, please see NantHealth's press release.